nodes	percent_of_prediction	percent_of_DWPC	metapath
Sitagliptin—ABCB1—Methylprednisolone—psoriatic arthritis	0.13	0.153	CbGbCtD
Sitagliptin—ABCB1—Betamethasone—psoriatic arthritis	0.0843	0.0992	CbGbCtD
Sitagliptin—ABCB1—Prednisolone—psoriatic arthritis	0.0831	0.0979	CbGbCtD
Sitagliptin—ABCB1—Prednisone—psoriatic arthritis	0.0785	0.0924	CbGbCtD
Sitagliptin—CYP3A4—Methylprednisolone—psoriatic arthritis	0.0776	0.0914	CbGbCtD
Sitagliptin—CYP2C8—Dexamethasone—psoriatic arthritis	0.0724	0.0852	CbGbCtD
Sitagliptin—CYP3A4—Triamcinolone—psoriatic arthritis	0.0588	0.0693	CbGbCtD
Sitagliptin—CYP3A4—Betamethasone—psoriatic arthritis	0.0505	0.0594	CbGbCtD
Sitagliptin—CYP3A4—Prednisolone—psoriatic arthritis	0.0498	0.0586	CbGbCtD
Sitagliptin—ABCB1—Dexamethasone—psoriatic arthritis	0.049	0.0577	CbGbCtD
Sitagliptin—CYP3A4—Prednisone—psoriatic arthritis	0.047	0.0554	CbGbCtD
Sitagliptin—ABCB1—Methotrexate—psoriatic arthritis	0.0394	0.0464	CbGbCtD
Sitagliptin—CYP3A4—Dexamethasone—psoriatic arthritis	0.0294	0.0346	CbGbCtD
Sitagliptin—Eye disorder—Methylprednisolone—psoriatic arthritis	0.000565	0.00375	CcSEcCtD
Sitagliptin—Cardiac disorder—Methylprednisolone—psoriatic arthritis	0.000561	0.00373	CcSEcCtD
Sitagliptin—Erectile dysfunction—Prednisone—psoriatic arthritis	0.000551	0.00366	CcSEcCtD
Sitagliptin—Angiopathy—Methylprednisolone—psoriatic arthritis	0.000548	0.00364	CcSEcCtD
Sitagliptin—Immune system disorder—Methylprednisolone—psoriatic arthritis	0.000546	0.00363	CcSEcCtD
Sitagliptin—Mediastinal disorder—Methylprednisolone—psoriatic arthritis	0.000545	0.00362	CcSEcCtD
Sitagliptin—Weight increased—Prednisone—psoriatic arthritis	0.000544	0.00362	CcSEcCtD
Sitagliptin—Vision blurred—Prednisolone—psoriatic arthritis	0.00054	0.00359	CcSEcCtD
Sitagliptin—Hyperglycaemia—Prednisone—psoriatic arthritis	0.00054	0.00358	CcSEcCtD
Sitagliptin—Ill-defined disorder—Prednisolone—psoriatic arthritis	0.000532	0.00353	CcSEcCtD
Sitagliptin—Depression—Prednisone—psoriatic arthritis	0.000532	0.00353	CcSEcCtD
Sitagliptin—Mental disorder—Methylprednisolone—psoriatic arthritis	0.00053	0.00352	CcSEcCtD
Sitagliptin—Malnutrition—Methylprednisolone—psoriatic arthritis	0.000526	0.0035	CcSEcCtD
Sitagliptin—Angioedema—Prednisolone—psoriatic arthritis	0.000524	0.00348	CcSEcCtD
Sitagliptin—Neuropathy peripheral—Prednisone—psoriatic arthritis	0.000523	0.00347	CcSEcCtD
Sitagliptin—Breast disorder—Methotrexate—psoriatic arthritis	0.000523	0.00347	CcSEcCtD
Sitagliptin—Malaise—Prednisolone—psoriatic arthritis	0.000517	0.00344	CcSEcCtD
Sitagliptin—Vertigo—Prednisolone—psoriatic arthritis	0.000515	0.00342	CcSEcCtD
Sitagliptin—Eye disorder—Betamethasone—psoriatic arthritis	0.000514	0.00341	CcSEcCtD
Sitagliptin—Eye disorder—Dexamethasone—psoriatic arthritis	0.000514	0.00341	CcSEcCtD
Sitagliptin—Back pain—Triamcinolone—psoriatic arthritis	0.00051	0.00339	CcSEcCtD
Sitagliptin—Angiopathy—Betamethasone—psoriatic arthritis	0.000499	0.00331	CcSEcCtD
Sitagliptin—Angiopathy—Dexamethasone—psoriatic arthritis	0.000499	0.00331	CcSEcCtD
Sitagliptin—Hypertension—Prednisolone—psoriatic arthritis	0.000495	0.00329	CcSEcCtD
Sitagliptin—Pancreatitis—Methotrexate—psoriatic arthritis	0.00049	0.00326	CcSEcCtD
Sitagliptin—Ill-defined disorder—Triamcinolone—psoriatic arthritis	0.000489	0.00325	CcSEcCtD
Sitagliptin—Ill-defined disorder—Methylprednisolone—psoriatic arthritis	0.000488	0.00324	CcSEcCtD
Sitagliptin—Discomfort—Prednisolone—psoriatic arthritis	0.000482	0.0032	CcSEcCtD
Sitagliptin—Angioedema—Triamcinolone—psoriatic arthritis	0.000482	0.0032	CcSEcCtD
Sitagliptin—Angioedema—Methylprednisolone—psoriatic arthritis	0.000481	0.00319	CcSEcCtD
Sitagliptin—Abdominal discomfort—Methotrexate—psoriatic arthritis	0.000479	0.00318	CcSEcCtD
Sitagliptin—Malaise—Triamcinolone—psoriatic arthritis	0.000476	0.00316	CcSEcCtD
Sitagliptin—Malaise—Methylprednisolone—psoriatic arthritis	0.000475	0.00315	CcSEcCtD
Sitagliptin—Vertigo—Triamcinolone—psoriatic arthritis	0.000474	0.00315	CcSEcCtD
Sitagliptin—Vertigo—Methylprednisolone—psoriatic arthritis	0.000473	0.00314	CcSEcCtD
Sitagliptin—Connective tissue disorder—Prednisone—psoriatic arthritis	0.00047	0.00313	CcSEcCtD
Sitagliptin—Anaphylactic shock—Prednisolone—psoriatic arthritis	0.000468	0.00311	CcSEcCtD
Sitagliptin—Upper respiratory tract infection—Methotrexate—psoriatic arthritis	0.000465	0.00309	CcSEcCtD
Sitagliptin—Erectile dysfunction—Methotrexate—psoriatic arthritis	0.00046	0.00306	CcSEcCtD
Sitagliptin—Cough—Triamcinolone—psoriatic arthritis	0.00046	0.00306	CcSEcCtD
Sitagliptin—Hypertension—Triamcinolone—psoriatic arthritis	0.000455	0.00302	CcSEcCtD
Sitagliptin—Hypertension—Methylprednisolone—psoriatic arthritis	0.000454	0.00302	CcSEcCtD
Sitagliptin—Myalgia—Triamcinolone—psoriatic arthritis	0.000449	0.00298	CcSEcCtD
Sitagliptin—Pneumonia—Methotrexate—psoriatic arthritis	0.000448	0.00298	CcSEcCtD
Sitagliptin—Myalgia—Methylprednisolone—psoriatic arthritis	0.000448	0.00298	CcSEcCtD
Sitagliptin—Arthralgia—Methylprednisolone—psoriatic arthritis	0.000448	0.00298	CcSEcCtD
Sitagliptin—Eye disorder—Prednisone—psoriatic arthritis	0.000447	0.00297	CcSEcCtD
Sitagliptin—Anxiety—Methylprednisolone—psoriatic arthritis	0.000446	0.00297	CcSEcCtD
Sitagliptin—Infestation NOS—Methotrexate—psoriatic arthritis	0.000446	0.00296	CcSEcCtD
Sitagliptin—Infestation—Methotrexate—psoriatic arthritis	0.000446	0.00296	CcSEcCtD
Sitagliptin—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.000445	0.00296	CcSEcCtD
Sitagliptin—Depression—Methotrexate—psoriatic arthritis	0.000444	0.00295	CcSEcCtD
Sitagliptin—Ill-defined disorder—Betamethasone—psoriatic arthritis	0.000444	0.00295	CcSEcCtD
Sitagliptin—Ill-defined disorder—Dexamethasone—psoriatic arthritis	0.000444	0.00295	CcSEcCtD
Sitagliptin—Discomfort—Triamcinolone—psoriatic arthritis	0.000444	0.00295	CcSEcCtD
Sitagliptin—Discomfort—Methylprednisolone—psoriatic arthritis	0.000443	0.00294	CcSEcCtD
Sitagliptin—Stevens-Johnson syndrome—Methotrexate—psoriatic arthritis	0.000442	0.00294	CcSEcCtD
Sitagliptin—Dry mouth—Triamcinolone—psoriatic arthritis	0.000439	0.00292	CcSEcCtD
Sitagliptin—Renal failure—Methotrexate—psoriatic arthritis	0.000438	0.00291	CcSEcCtD
Sitagliptin—Angioedema—Dexamethasone—psoriatic arthritis	0.000437	0.0029	CcSEcCtD
Sitagliptin—Angioedema—Betamethasone—psoriatic arthritis	0.000437	0.0029	CcSEcCtD
Sitagliptin—Angiopathy—Prednisone—psoriatic arthritis	0.000434	0.00289	CcSEcCtD
Sitagliptin—Immune system disorder—Prednisone—psoriatic arthritis	0.000432	0.00287	CcSEcCtD
Sitagliptin—Malaise—Dexamethasone—psoriatic arthritis	0.000432	0.00287	CcSEcCtD
Sitagliptin—Malaise—Betamethasone—psoriatic arthritis	0.000432	0.00287	CcSEcCtD
Sitagliptin—Anaphylactic shock—Triamcinolone—psoriatic arthritis	0.00043	0.00286	CcSEcCtD
Sitagliptin—Vertigo—Betamethasone—psoriatic arthritis	0.00043	0.00286	CcSEcCtD
Sitagliptin—Vertigo—Dexamethasone—psoriatic arthritis	0.00043	0.00286	CcSEcCtD
Sitagliptin—Anaphylactic shock—Methylprednisolone—psoriatic arthritis	0.000429	0.00285	CcSEcCtD
Sitagliptin—Infection—Triamcinolone—psoriatic arthritis	0.000428	0.00284	CcSEcCtD
Sitagliptin—Infection—Methylprednisolone—psoriatic arthritis	0.000427	0.00283	CcSEcCtD
Sitagliptin—Insomnia—Prednisolone—psoriatic arthritis	0.000423	0.00281	CcSEcCtD
Sitagliptin—Hepatobiliary disease—Methotrexate—psoriatic arthritis	0.000421	0.0028	CcSEcCtD
Sitagliptin—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.000421	0.0028	CcSEcCtD
Sitagliptin—Mental disorder—Prednisone—psoriatic arthritis	0.000419	0.00279	CcSEcCtD
Sitagliptin—Skin disorder—Methylprednisolone—psoriatic arthritis	0.000417	0.00277	CcSEcCtD
Sitagliptin—Malnutrition—Prednisone—psoriatic arthritis	0.000417	0.00277	CcSEcCtD
Sitagliptin—Hypertension—Betamethasone—psoriatic arthritis	0.000413	0.00274	CcSEcCtD
Sitagliptin—Hypertension—Dexamethasone—psoriatic arthritis	0.000413	0.00274	CcSEcCtD
Sitagliptin—Myalgia—Dexamethasone—psoriatic arthritis	0.000407	0.00271	CcSEcCtD
Sitagliptin—Myalgia—Betamethasone—psoriatic arthritis	0.000407	0.00271	CcSEcCtD
Sitagliptin—Anxiety—Dexamethasone—psoriatic arthritis	0.000406	0.0027	CcSEcCtD
Sitagliptin—Anxiety—Betamethasone—psoriatic arthritis	0.000406	0.0027	CcSEcCtD
Sitagliptin—Discomfort—Betamethasone—psoriatic arthritis	0.000403	0.00267	CcSEcCtD
Sitagliptin—Discomfort—Dexamethasone—psoriatic arthritis	0.000403	0.00267	CcSEcCtD
Sitagliptin—Pain—Prednisolone—psoriatic arthritis	0.0004	0.00266	CcSEcCtD
Sitagliptin—Pharyngitis—Methotrexate—psoriatic arthritis	0.000397	0.00264	CcSEcCtD
Sitagliptin—Urinary tract disorder—Methotrexate—psoriatic arthritis	0.000395	0.00262	CcSEcCtD
Sitagliptin—Vision blurred—Prednisone—psoriatic arthritis	0.000393	0.00261	CcSEcCtD
Sitagliptin—Urethral disorder—Methotrexate—psoriatic arthritis	0.000392	0.00261	CcSEcCtD
Sitagliptin—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.000392	0.00261	CcSEcCtD
Sitagliptin—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.000391	0.0026	CcSEcCtD
Sitagliptin—Anaphylactic shock—Dexamethasone—psoriatic arthritis	0.000391	0.00259	CcSEcCtD
Sitagliptin—Anaphylactic shock—Betamethasone—psoriatic arthritis	0.000391	0.00259	CcSEcCtD
Sitagliptin—Insomnia—Triamcinolone—psoriatic arthritis	0.000389	0.00259	CcSEcCtD
Sitagliptin—Insomnia—Methylprednisolone—psoriatic arthritis	0.000388	0.00258	CcSEcCtD
Sitagliptin—Infection—Dexamethasone—psoriatic arthritis	0.000388	0.00258	CcSEcCtD
Sitagliptin—Infection—Betamethasone—psoriatic arthritis	0.000388	0.00258	CcSEcCtD
Sitagliptin—Ill-defined disorder—Prednisone—psoriatic arthritis	0.000387	0.00257	CcSEcCtD
Sitagliptin—Feeling abnormal—Prednisolone—psoriatic arthritis	0.000386	0.00256	CcSEcCtD
Sitagliptin—Nervous system disorder—Betamethasone—psoriatic arthritis	0.000383	0.00254	CcSEcCtD
Sitagliptin—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.000383	0.00254	CcSEcCtD
Sitagliptin—Angioedema—Prednisone—psoriatic arthritis	0.000381	0.00253	CcSEcCtD
Sitagliptin—Dyspepsia—Triamcinolone—psoriatic arthritis	0.000379	0.00252	CcSEcCtD
Sitagliptin—Erythema multiforme—Methotrexate—psoriatic arthritis	0.000378	0.00251	CcSEcCtD
Sitagliptin—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.000378	0.00251	CcSEcCtD
Sitagliptin—Malaise—Prednisone—psoriatic arthritis	0.000376	0.0025	CcSEcCtD
Sitagliptin—Vertigo—Prednisone—psoriatic arthritis	0.000374	0.00249	CcSEcCtD
Sitagliptin—Eye disorder—Methotrexate—psoriatic arthritis	0.000374	0.00248	CcSEcCtD
Sitagliptin—Urticaria—Prednisolone—psoriatic arthritis	0.000372	0.00247	CcSEcCtD
Sitagliptin—Cardiac disorder—Methotrexate—psoriatic arthritis	0.000371	0.00247	CcSEcCtD
Sitagliptin—Fatigue—Triamcinolone—psoriatic arthritis	0.000371	0.00247	CcSEcCtD
Sitagliptin—Fatigue—Methylprednisolone—psoriatic arthritis	0.00037	0.00246	CcSEcCtD
Sitagliptin—Pain—Triamcinolone—psoriatic arthritis	0.000368	0.00245	CcSEcCtD
Sitagliptin—Angiopathy—Methotrexate—psoriatic arthritis	0.000363	0.00241	CcSEcCtD
Sitagliptin—Immune system disorder—Methotrexate—psoriatic arthritis	0.000361	0.0024	CcSEcCtD
Sitagliptin—Mediastinal disorder—Methotrexate—psoriatic arthritis	0.000361	0.0024	CcSEcCtD
Sitagliptin—Hypertension—Prednisone—psoriatic arthritis	0.00036	0.00239	CcSEcCtD
Sitagliptin—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.000356	0.00236	CcSEcCtD
Sitagliptin—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.000356	0.00236	CcSEcCtD
Sitagliptin—Myalgia—Prednisone—psoriatic arthritis	0.000355	0.00236	CcSEcCtD
Sitagliptin—Arthralgia—Prednisone—psoriatic arthritis	0.000355	0.00236	CcSEcCtD
Sitagliptin—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.000355	0.00236	CcSEcCtD
Sitagliptin—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.000354	0.00235	CcSEcCtD
Sitagliptin—Anxiety—Prednisone—psoriatic arthritis	0.000354	0.00235	CcSEcCtD
Sitagliptin—Insomnia—Betamethasone—psoriatic arthritis	0.000353	0.00235	CcSEcCtD
Sitagliptin—Insomnia—Dexamethasone—psoriatic arthritis	0.000353	0.00235	CcSEcCtD
Sitagliptin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.000352	0.00234	CcSEcCtD
Sitagliptin—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.000351	0.00233	CcSEcCtD
Sitagliptin—Discomfort—Prednisone—psoriatic arthritis	0.000351	0.00233	CcSEcCtD
Sitagliptin—Mental disorder—Methotrexate—psoriatic arthritis	0.000351	0.00233	CcSEcCtD
Sitagliptin—Malnutrition—Methotrexate—psoriatic arthritis	0.000348	0.00231	CcSEcCtD
Sitagliptin—Hypersensitivity—Prednisolone—psoriatic arthritis	0.000345	0.00229	CcSEcCtD
Sitagliptin—Dyspepsia—Betamethasone—psoriatic arthritis	0.000344	0.00228	CcSEcCtD
Sitagliptin—Dyspepsia—Dexamethasone—psoriatic arthritis	0.000344	0.00228	CcSEcCtD
Sitagliptin—Urticaria—Triamcinolone—psoriatic arthritis	0.000342	0.00227	CcSEcCtD
Sitagliptin—Urticaria—Methylprednisolone—psoriatic arthritis	0.000341	0.00227	CcSEcCtD
Sitagliptin—Anaphylactic shock—Prednisone—psoriatic arthritis	0.00034	0.00226	CcSEcCtD
Sitagliptin—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.000339	0.00226	CcSEcCtD
Sitagliptin—Decreased appetite—Betamethasone—psoriatic arthritis	0.000339	0.00226	CcSEcCtD
Sitagliptin—Decreased appetite—Dexamethasone—psoriatic arthritis	0.000339	0.00226	CcSEcCtD
Sitagliptin—Infection—Prednisone—psoriatic arthritis	0.000338	0.00224	CcSEcCtD
Sitagliptin—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.000337	0.00224	CcSEcCtD
Sitagliptin—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.000337	0.00224	CcSEcCtD
Sitagliptin—Back pain—Methotrexate—psoriatic arthritis	0.000337	0.00224	CcSEcCtD
Sitagliptin—Fatigue—Dexamethasone—psoriatic arthritis	0.000337	0.00224	CcSEcCtD
Sitagliptin—Fatigue—Betamethasone—psoriatic arthritis	0.000337	0.00224	CcSEcCtD
Sitagliptin—Pain—Betamethasone—psoriatic arthritis	0.000334	0.00222	CcSEcCtD
Sitagliptin—Pain—Dexamethasone—psoriatic arthritis	0.000334	0.00222	CcSEcCtD
Sitagliptin—Nervous system disorder—Prednisone—psoriatic arthritis	0.000334	0.00222	CcSEcCtD
Sitagliptin—Skin disorder—Prednisone—psoriatic arthritis	0.00033	0.00219	CcSEcCtD
Sitagliptin—Vision blurred—Methotrexate—psoriatic arthritis	0.000328	0.00218	CcSEcCtD
Sitagliptin—Ill-defined disorder—Methotrexate—psoriatic arthritis	0.000323	0.00215	CcSEcCtD
Sitagliptin—Feeling abnormal—Betamethasone—psoriatic arthritis	0.000322	0.00214	CcSEcCtD
Sitagliptin—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.000322	0.00214	CcSEcCtD
Sitagliptin—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.000319	0.00212	CcSEcCtD
Sitagliptin—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.000319	0.00212	CcSEcCtD
Sitagliptin—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.000317	0.00211	CcSEcCtD
Sitagliptin—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.000316	0.0021	CcSEcCtD
Sitagliptin—Malaise—Methotrexate—psoriatic arthritis	0.000314	0.00209	CcSEcCtD
Sitagliptin—Vertigo—Methotrexate—psoriatic arthritis	0.000313	0.00208	CcSEcCtD
Sitagliptin—Urticaria—Dexamethasone—psoriatic arthritis	0.00031	0.00206	CcSEcCtD
Sitagliptin—Urticaria—Betamethasone—psoriatic arthritis	0.00031	0.00206	CcSEcCtD
Sitagliptin—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.00031	0.00206	CcSEcCtD
Sitagliptin—Dizziness—Prednisolone—psoriatic arthritis	0.00031	0.00206	CcSEcCtD
Sitagliptin—Asthenia—Triamcinolone—psoriatic arthritis	0.000309	0.00205	CcSEcCtD
Sitagliptin—Abdominal pain—Dexamethasone—psoriatic arthritis	0.000309	0.00205	CcSEcCtD
Sitagliptin—Abdominal pain—Betamethasone—psoriatic arthritis	0.000309	0.00205	CcSEcCtD
Sitagliptin—Asthenia—Methylprednisolone—psoriatic arthritis	0.000308	0.00205	CcSEcCtD
Sitagliptin—Insomnia—Prednisone—psoriatic arthritis	0.000308	0.00204	CcSEcCtD
Sitagliptin—Cough—Methotrexate—psoriatic arthritis	0.000304	0.00202	CcSEcCtD
Sitagliptin—Dyspepsia—Prednisone—psoriatic arthritis	0.000299	0.00199	CcSEcCtD
Sitagliptin—Myalgia—Methotrexate—psoriatic arthritis	0.000297	0.00197	CcSEcCtD
Sitagliptin—Arthralgia—Methotrexate—psoriatic arthritis	0.000297	0.00197	CcSEcCtD
Sitagliptin—Decreased appetite—Prednisone—psoriatic arthritis	0.000296	0.00196	CcSEcCtD
Sitagliptin—Rash—Prednisolone—psoriatic arthritis	0.000295	0.00196	CcSEcCtD
Sitagliptin—Dermatitis—Prednisolone—psoriatic arthritis	0.000295	0.00196	CcSEcCtD
Sitagliptin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.000294	0.00196	CcSEcCtD
Sitagliptin—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.000294	0.00195	CcSEcCtD
Sitagliptin—Fatigue—Prednisone—psoriatic arthritis	0.000293	0.00195	CcSEcCtD
Sitagliptin—Headache—Prednisolone—psoriatic arthritis	0.000293	0.00195	CcSEcCtD
Sitagliptin—Discomfort—Methotrexate—psoriatic arthritis	0.000293	0.00195	CcSEcCtD
Sitagliptin—Constipation—Prednisone—psoriatic arthritis	0.000291	0.00193	CcSEcCtD
Sitagliptin—Dizziness—Triamcinolone—psoriatic arthritis	0.000285	0.00189	CcSEcCtD
Sitagliptin—Anaphylactic shock—Methotrexate—psoriatic arthritis	0.000284	0.00189	CcSEcCtD
Sitagliptin—Dizziness—Methylprednisolone—psoriatic arthritis	0.000284	0.00189	CcSEcCtD
Sitagliptin—Infection—Methotrexate—psoriatic arthritis	0.000282	0.00188	CcSEcCtD
Sitagliptin—Feeling abnormal—Prednisone—psoriatic arthritis	0.00028	0.00186	CcSEcCtD
Sitagliptin—Asthenia—Dexamethasone—psoriatic arthritis	0.00028	0.00186	CcSEcCtD
Sitagliptin—Asthenia—Betamethasone—psoriatic arthritis	0.00028	0.00186	CcSEcCtD
Sitagliptin—Nervous system disorder—Methotrexate—psoriatic arthritis	0.000279	0.00185	CcSEcCtD
Sitagliptin—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.000278	0.00185	CcSEcCtD
Sitagliptin—Nausea—Prednisolone—psoriatic arthritis	0.000278	0.00185	CcSEcCtD
Sitagliptin—Skin disorder—Methotrexate—psoriatic arthritis	0.000276	0.00183	CcSEcCtD
Sitagliptin—Vomiting—Triamcinolone—psoriatic arthritis	0.000274	0.00182	CcSEcCtD
Sitagliptin—Vomiting—Methylprednisolone—psoriatic arthritis	0.000273	0.00181	CcSEcCtD
Sitagliptin—Rash—Triamcinolone—psoriatic arthritis	0.000271	0.0018	CcSEcCtD
Sitagliptin—Dermatitis—Triamcinolone—psoriatic arthritis	0.000271	0.0018	CcSEcCtD
Sitagliptin—Rash—Methylprednisolone—psoriatic arthritis	0.000271	0.0018	CcSEcCtD
Sitagliptin—Dermatitis—Methylprednisolone—psoriatic arthritis	0.000271	0.0018	CcSEcCtD
Sitagliptin—Urticaria—Prednisone—psoriatic arthritis	0.00027	0.00179	CcSEcCtD
Sitagliptin—Headache—Triamcinolone—psoriatic arthritis	0.00027	0.00179	CcSEcCtD
Sitagliptin—Headache—Methylprednisolone—psoriatic arthritis	0.000269	0.00179	CcSEcCtD
Sitagliptin—Abdominal pain—Prednisone—psoriatic arthritis	0.000269	0.00179	CcSEcCtD
Sitagliptin—Diarrhoea—Betamethasone—psoriatic arthritis	0.000267	0.00178	CcSEcCtD
Sitagliptin—Diarrhoea—Dexamethasone—psoriatic arthritis	0.000267	0.00178	CcSEcCtD
Sitagliptin—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.000259	0.00172	CcSEcCtD
Sitagliptin—Dizziness—Dexamethasone—psoriatic arthritis	0.000258	0.00172	CcSEcCtD
Sitagliptin—Dizziness—Betamethasone—psoriatic arthritis	0.000258	0.00172	CcSEcCtD
Sitagliptin—Insomnia—Methotrexate—psoriatic arthritis	0.000257	0.00171	CcSEcCtD
Sitagliptin—Nausea—Triamcinolone—psoriatic arthritis	0.000256	0.0017	CcSEcCtD
Sitagliptin—Nausea—Methylprednisolone—psoriatic arthritis	0.000255	0.00169	CcSEcCtD
Sitagliptin—Somnolence—Methotrexate—psoriatic arthritis	0.000253	0.00168	CcSEcCtD
Sitagliptin—Hypersensitivity—Prednisone—psoriatic arthritis	0.000251	0.00166	CcSEcCtD
Sitagliptin—Dyspepsia—Methotrexate—psoriatic arthritis	0.00025	0.00166	CcSEcCtD
Sitagliptin—Vomiting—Betamethasone—psoriatic arthritis	0.000248	0.00165	CcSEcCtD
Sitagliptin—Vomiting—Dexamethasone—psoriatic arthritis	0.000248	0.00165	CcSEcCtD
Sitagliptin—Decreased appetite—Methotrexate—psoriatic arthritis	0.000247	0.00164	CcSEcCtD
Sitagliptin—Rash—Dexamethasone—psoriatic arthritis	0.000246	0.00164	CcSEcCtD
Sitagliptin—Rash—Betamethasone—psoriatic arthritis	0.000246	0.00164	CcSEcCtD
Sitagliptin—Dermatitis—Dexamethasone—psoriatic arthritis	0.000246	0.00163	CcSEcCtD
Sitagliptin—Dermatitis—Betamethasone—psoriatic arthritis	0.000246	0.00163	CcSEcCtD
Sitagliptin—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.000245	0.00163	CcSEcCtD
Sitagliptin—Fatigue—Methotrexate—psoriatic arthritis	0.000245	0.00163	CcSEcCtD
Sitagliptin—Headache—Dexamethasone—psoriatic arthritis	0.000245	0.00163	CcSEcCtD
Sitagliptin—Headache—Betamethasone—psoriatic arthritis	0.000245	0.00163	CcSEcCtD
Sitagliptin—Asthenia—Prednisone—psoriatic arthritis	0.000244	0.00162	CcSEcCtD
Sitagliptin—Pain—Methotrexate—psoriatic arthritis	0.000243	0.00161	CcSEcCtD
Sitagliptin—Feeling abnormal—Methotrexate—psoriatic arthritis	0.000234	0.00156	CcSEcCtD
Sitagliptin—Diarrhoea—Prednisone—psoriatic arthritis	0.000233	0.00155	CcSEcCtD
Sitagliptin—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.000232	0.00154	CcSEcCtD
Sitagliptin—Nausea—Dexamethasone—psoriatic arthritis	0.000232	0.00154	CcSEcCtD
Sitagliptin—Nausea—Betamethasone—psoriatic arthritis	0.000232	0.00154	CcSEcCtD
Sitagliptin—Urticaria—Methotrexate—psoriatic arthritis	0.000226	0.0015	CcSEcCtD
Sitagliptin—Dizziness—Prednisone—psoriatic arthritis	0.000225	0.00149	CcSEcCtD
Sitagliptin—Abdominal pain—Methotrexate—psoriatic arthritis	0.000225	0.00149	CcSEcCtD
Sitagliptin—Vomiting—Prednisone—psoriatic arthritis	0.000216	0.00144	CcSEcCtD
Sitagliptin—Rash—Prednisone—psoriatic arthritis	0.000214	0.00142	CcSEcCtD
Sitagliptin—Dermatitis—Prednisone—psoriatic arthritis	0.000214	0.00142	CcSEcCtD
Sitagliptin—Headache—Prednisone—psoriatic arthritis	0.000213	0.00142	CcSEcCtD
Sitagliptin—Hypersensitivity—Methotrexate—psoriatic arthritis	0.000209	0.00139	CcSEcCtD
Sitagliptin—Asthenia—Methotrexate—psoriatic arthritis	0.000204	0.00135	CcSEcCtD
Sitagliptin—Nausea—Prednisone—psoriatic arthritis	0.000202	0.00134	CcSEcCtD
Sitagliptin—Diarrhoea—Methotrexate—psoriatic arthritis	0.000194	0.00129	CcSEcCtD
Sitagliptin—Dizziness—Methotrexate—psoriatic arthritis	0.000188	0.00125	CcSEcCtD
Sitagliptin—Vomiting—Methotrexate—psoriatic arthritis	0.000181	0.0012	CcSEcCtD
Sitagliptin—Rash—Methotrexate—psoriatic arthritis	0.000179	0.00119	CcSEcCtD
Sitagliptin—Dermatitis—Methotrexate—psoriatic arthritis	0.000179	0.00119	CcSEcCtD
Sitagliptin—Headache—Methotrexate—psoriatic arthritis	0.000178	0.00118	CcSEcCtD
Sitagliptin—Nausea—Methotrexate—psoriatic arthritis	0.000169	0.00112	CcSEcCtD
